Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome. - Wikidata - wikimedia - TriplyDB

Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome.

Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome.

http://www.wikidata.org/entity/Q37434362

about

Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis.The effect of weight loss on HDL subfractions and LCAT activity in two genotypes of APOA-II -265T>C polymorphism Weight change in control group participants in behavioural weight loss interventions: a systematic review and meta-regression study.Effect of rosiglitazone on HDL metabolism in subjects with metabolic syndrome and low HDL.Correlation between mesenteric fat thickness and serum apolipoproteins in patients with peripheral arterial occlusive disease.Dietary strategies to reduce metabolic syndrome.Triglyceride increase in the core of high-density lipoproteins augments apolipoprotein dissociation from the surface: Potential implications for treatment of apolipoprotein deposition diseases.

P2860

Q33620112-1F8E60E5-19B2-4FDF-B1E5-502094290183 Q33730096-E762230F-195B-40A8-847C-796FCA9FA18A Q34371123-B403D3A2-3038-421C-ACA3-61C3B3DFACC8 Q34395184-939CDC3B-6C56-4B75-AE2E-2155076BE841 Q36335132-3022AF68-130C-497E-820D-4ED83F9B7E5A Q38128783-B50698AE-5FE2-4A3B-9EF8-9FA557C25E4E Q48962618-A0611CF4-BA46-466E-82D1-11046C920AFE

P2860

Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome.

http://www.wikidata.org/entity/Q37434362

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 October 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome.

@en

Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome.

@nl

type

label

Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome.

@en

Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome.

@nl

prefLabel

Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome.

@en

Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome.

@nl

P1433

Q37434362-D5067E3C-1DE9-4264-B343-8794E10CB68D

P1476

Q37434362-E9DE5A9B-9B26-48C8-A62E-64B744A724A9

P2093

Q37434362-0F2AD15E-7FA1-4194-98A1-61FE0E51F177

Q37434362-72923804-3821-4572-A976-2EACCB57B63B

Q37434362-C57C41C1-0C6A-4BA7-ADAF-5CFB688B313B

Q37434362-F08D9B73-E189-4993-88E7-A2EC81559968

P2860

Q37434362-01D9CBB5-F109-4EE7-AEB2-B48D6A3C0C76

Q37434362-03029623-18A6-4DF9-A1DF-FDD65BA5D61D

Q37434362-0B420BFE-1F1B-44BA-915B-5BB1612A3999

Q37434362-1CAF4B3A-8140-49C7-B19F-D00F4766E863

Q37434362-217952F4-4F77-4E23-9493-70CD3CEBD809

Q37434362-3225DDB9-CD7A-4374-A482-91B584AD5DAC

Q37434362-381625B8-3E91-4CC4-8BC6-EE54BFEC55A8

Q37434362-62935690-27B8-49F1-BF44-9E51FCF38B14

Q37434362-62E880F3-A6F1-4129-BD74-6B4F32035A58

Q37434362-66AE97B5-906D-4773-B2C4-94FF6EBB43EF

P304

Q37434362-FE7A0769-1C9A-4EC8-B006-F051CA1D35FC

P31

Q37434362-C4302104-8069-41D1-9530-2D43E9681914

P356

Q37434362-87C739B9-3AC2-4BCB-94DD-D1A79633FEB1

P407

Q37434362-66E3263B-FF8F-45EA-A6F9-1ACD5E68C1A0

P433

Q37434362-592A1F58-3192-47F3-AFA8-70FB538E545E

P478

Q37434362-8D6E18B9-F0A3-4654-B73A-3D04A18CDAD7

P50

Q37434362-5E7B1B1F-154E-425B-A914-4B65671CB524

Q37434362-88300A94-1E84-4AB7-A23F-E65B7E39CCEA

Q37434362-C7A2DBC8-EFC7-42E5-9730-1833B4986CC0

Q37434362-F7520DF4-9C94-4958-B9C3-D5EEDBFA69B4

P577

Q37434362-2E57528F-BDB3-4EA0-B031-2CA84B3549AA

P698

Q37434362-0CA5734F-D81E-4AE1-B096-D1E5CB8854D8

P921

Q37434362-E1616A06-48F7-47E7-9B2C-E901DAA5B33D

P932

Q37434362-45D354D1-51B6-4202-B948-A4DC782EBF66

P356

P1433

Clinical Science

P1476

Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome

@en

P2093

Dick C Chan

http://www.w3.org/2001/XMLSchema#string

Gerald F Watts

http://www.w3.org/2001/XMLSchema#string

P Hugh R Barrett

http://www.w3.org/2001/XMLSchema#string

Theodore W K Ng

http://www.w3.org/2001/XMLSchema#string

P2860

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein

Metabolic syndrome: a multiplex cardiovascular risk factor

HDL metabolism in hypertriglyceridemic states: an overview.

A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates

High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies.

Diabetic dyslipidaemia: from basic research to clinical practice.

Mechanisms of disease: HDL metabolism as a target for novel therapies.

Plasma apolipoprotein C-III transport in centrally obese men: associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism.

Apolipoprotein A-II is inversely associated with risk of future coronary artery disease.

P304

79-85

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1042/CS20090110

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P50

Theodore W K Ng

P577

2009-10-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19456294

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome

P932

2782318

http://www.w3.org/2001/XMLSchema#string